Efficacy and Immune Response Elicited by Gold Nanoparticle- Based Nanovaccines against Infectious Diseases

The use of nanoparticles for developing vaccines has become a routine process for researchers and pharmaceutical companies. Gold nanoparticles (GNPs) are chemical inert, have low toxicity, and are easy to modify and functionalize, making them an attractive choice for nanovaccine development. GNPs ar...

Descripción completa

Detalles Bibliográficos
Autores principales: Sengupta, Anirban, Azharuddin, Mohammad, Al-Otaibi, Noha, Hinkula, Jorma
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9030786/
https://www.ncbi.nlm.nih.gov/pubmed/35455254
http://dx.doi.org/10.3390/vaccines10040505

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9030786/
https://www.ncbi.nlm.nih.gov/pubmed/35455254
http://dx.doi.org/10.3390/vaccines10040505

Ejemplares similares